Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NEWTOWN, Pa., May 19, 2023 -- Helius Medical Technologies, Inc. , a neurotech company focused on neurological wellness, today announced that, effective May 18, 2023, its independent directors... | June 11, 2023

Related Keywords

United States ,Australia ,Canada , ,Therapeutic Experience Program ,Company Class ,Nasdaq ,Helius Medical Technologies Inc ,Medical Technologies ,Nasdaq Listing Rule ,Helius Medical Technologies ,Portable Neuromodulation Stimulator ,